INSULET CORP (PODD)

US45784P1012 - Common Stock

184.225  +7.82 (+4.44%)

Fundamental Rating

6

Taking everything into account, PODD scores 6 out of 10 in our fundamental rating. PODD was compared to 193 industry peers in the Health Care Equipment & Supplies industry. PODD has an excellent profitability rating, but there are some minor concerns on its financial health. PODD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PODD suitable for growth investing!



8

1. Profitability

1.1 Basic Checks

PODD had positive earnings in the past year.
In the past year PODD had a positive cash flow from operations.
PODD had positive earnings in each of the past 5 years.
PODD had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of PODD (7.97%) is better than 89.06% of its industry peers.
With an excellent Return On Equity value of 28.16%, PODD belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.36%, PODD belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PODD is below the industry average of 8.51%.
The 3 year average ROIC (4.58%) for PODD is below the current ROIC(7.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.97%
ROE 28.16%
ROIC 7.36%
ROA(3y)3%
ROA(5y)2.07%
ROE(3y)10.71%
ROE(5y)9.71%
ROIC(3y)4.58%
ROIC(5y)3.92%

1.3 Margins

The Profit Margin of PODD (12.16%) is better than 89.58% of its industry peers.
PODD's Profit Margin has improved in the last couple of years.
PODD's Operating Margin of 12.96% is amongst the best of the industry. PODD outperforms 82.81% of its industry peers.
PODD's Operating Margin has improved in the last couple of years.
PODD has a better Gross Margin (68.35%) than 76.56% of its industry peers.
In the last couple of years the Gross Margin of PODD has remained more or less at the same level.
Industry RankSector Rank
OM 12.96%
PM (TTM) 12.16%
GM 68.35%
OM growth 3Y31.55%
OM growth 5Y12.81%
PM growth 3Y152.86%
PM growth 5Y83.43%
GM growth 3Y2.01%
GM growth 5Y0.8%

5

2. Health

2.1 Basic Checks

PODD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PODD has been increased compared to 1 year ago.
Compared to 5 years ago, PODD has more shares outstanding
The debt/assets ratio for PODD has been reduced compared to a year ago.

2.2 Solvency

PODD has an Altman-Z score of 5.25. This indicates that PODD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.25, PODD is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
The Debt to FCF ratio of PODD is 38.79, which is on the high side as it means it would take PODD, 38.79 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 38.79, PODD is doing good in the industry, outperforming 68.75% of the companies in the same industry.
PODD has a Debt/Equity ratio of 1.86. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.86, PODD is not doing good in the industry: 84.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF 38.79
Altman-Z 5.25
ROIC/WACC0.79
WACC9.36%

2.3 Liquidity

A Current Ratio of 3.51 indicates that PODD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.51, PODD is in line with its industry, outperforming 52.60% of the companies in the same industry.
PODD has a Quick Ratio of 2.62. This indicates that PODD is financially healthy and has no problem in meeting its short term obligations.
PODD has a Quick ratio of 2.62. This is comparable to the rest of the industry: PODD outperforms 53.13% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 2.62

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 455.10% over the past year.
The Earnings Per Share has been growing by 122.39% on average over the past years. This is a very strong growth
Looking at the last year, PODD shows a very strong growth in Revenue. The Revenue has grown by 30.02%.
The Revenue has been growing by 24.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)455.1%
EPS 3Y104.08%
EPS 5Y122.39%
EPS growth Q2Q483.33%
Revenue 1Y (TTM)30.02%
Revenue growth 3Y23.34%
Revenue growth 5Y24.66%
Revenue growth Q2Q37.9%

3.2 Future

Based on estimates for the next years, PODD will show a very strong growth in Earnings Per Share. The EPS will grow by 23.37% on average per year.
Based on estimates for the next years, PODD will show a quite strong growth in Revenue. The Revenue will grow by 16.00% on average per year.
EPS Next Y12.04%
EPS Next 2Y19.19%
EPS Next 3Y21.98%
EPS Next 5Y23.37%
Revenue Next Year19.04%
Revenue Next 2Y18.79%
Revenue Next 3Y18.4%
Revenue Next 5Y16%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 67.73, the valuation of PODD can be described as expensive.
Based on the Price/Earnings ratio, PODD is valued a bit cheaper than the industry average as 70.31% of the companies are valued more expensively.
PODD is valuated expensively when we compare the Price/Earnings ratio to 28.02, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 60.45 indicates a quite expensive valuation of PODD.
71.35% of the companies in the same industry are more expensive than PODD, based on the Price/Forward Earnings ratio.
PODD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.58.
Industry RankSector Rank
PE 67.73
Fwd PE 60.45

4.2 Price Multiples

PODD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PODD is cheaper than 69.79% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PODD is valued a bit cheaper than the industry average as 69.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 353.41
EV/EBITDA 44.8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PODD has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PODD's earnings are expected to grow with 21.98% in the coming years.
PEG (NY)5.63
PEG (5Y)0.55
EPS Next 2Y19.19%
EPS Next 3Y21.98%

0

5. Dividend

5.1 Amount

PODD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INSULET CORP

NASDAQ:PODD (5/7/2024, 9:59:01 AM)

184.225

+7.82 (+4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.90B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 67.73
Fwd PE 60.45
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.63
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 28.16%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.96%
PM (TTM) 12.16%
GM 68.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.86
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.51
Quick Ratio 2.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)455.1%
EPS 3Y104.08%
EPS 5Y
EPS growth Q2Q
EPS Next Y12.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.02%
Revenue growth 3Y23.34%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y